Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Lerer

Showing results (61-70 of 147) with videos related to

Pageof 15
Sort By:
The International Journal of Neuropsychopharmacology|June 7, 2008
Cerebral perfusion after a 2-year remission in major depressionYoav Kohn, Nanette Freedman, Hava Lester, et al.
The International Journal of Neuropsychopharmacology|April 3, 2001
An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201Avraham Amar, Ronnen H. Segman, Shlomo Shtrussberg, et al.
Psychiatry Research|April 13, 2011
Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implicationsNoa Vardi, Nanette Freedman, Hava Lester, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2011
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse modelLior Greenbaum, Tzuri Lifschytz, Polina Zozulinsky, et al.
The International Journal of Neuropsychopharmacology|November 2, 2011
Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvementTzuri Lifschytz, Esther Channah Broner, Polina Zozulinsky, et al.
Convulsive Therapy|January 1, 1991
Change in Attitude Toward Electroconvulsive Therapy: Effects of Treatment, Time Since Treatment, and Severity of DepressionAvraham Calev, Elena Kochav-Lev, Nurith Tubi, et al.
Current Drug Targets|February 16, 2006
Basic mechanisms of augmentation of antidepressant effects with thyroid hormoneTsuri Lifschytz, Ronen Segman, Galit Shalom, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Journal of Affective Disorders|July 29, 2010
Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcomeMoshe Isserles, Oded Rosenberg, Pinchas Dannon, et al.
Molecular Psychiatry|October 11, 2024
Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-groomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Pageof 15

Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
The International Journal of Neuropsychopharmacology|June 7, 2008
Cerebral perfusion after a 2-year remission in major depressionYoav Kohn, Nanette Freedman, Hava Lester, et al.
The International Journal of Neuropsychopharmacology|April 3, 2001
An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201Avraham Amar, Ronnen H. Segman, Shlomo Shtrussberg, et al.
Psychiatry Research|April 13, 2011
Hyperintensities on T2-weighted images in the basal ganglia of patients with major depression: cerebral perfusion and clinical implicationsNoa Vardi, Nanette Freedman, Hava Lester, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 11, 2011
Alteration in RGS2 expression level is associated with changes in haloperidol induced extrapyramidal features in a mutant mouse modelLior Greenbaum, Tzuri Lifschytz, Polina Zozulinsky, et al.
The International Journal of Neuropsychopharmacology|November 2, 2011
Relationship between Rgs2 gene expression level and anxiety and depression-like behaviour in a mutant mouse model: serotonergic involvementTzuri Lifschytz, Esther Channah Broner, Polina Zozulinsky, et al.
Convulsive Therapy|January 1, 1991
Change in Attitude Toward Electroconvulsive Therapy: Effects of Treatment, Time Since Treatment, and Severity of DepressionAvraham Calev, Elena Kochav-Lev, Nurith Tubi, et al.
Current Drug Targets|February 16, 2006
Basic mechanisms of augmentation of antidepressant effects with thyroid hormoneTsuri Lifschytz, Ronen Segman, Galit Shalom, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Journal of Affective Disorders|July 29, 2010
Cognitive-emotional reactivation during deep transcranial magnetic stimulation over the prefrontal cortex of depressive patients affects antidepressant outcomeMoshe Isserles, Oded Rosenberg, Pinchas Dannon, et al.
Molecular Psychiatry|October 11, 2024
Striking long-term beneficial effects of single dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-groomingMichal Brownstien, Michal Lazar, Alexander Botvinnik, et al.
Pageof 15